Airborne L-Band Satcom Market
Airborne L-band satcom is a network satellite system applied to communication. Unmanned aerial v ... Read More
Nephrology Drugs Market, Global Outlook and Forecast 2024-2031
1 Introduction to Research & Analysis Reports
1.1 Nephrology Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Nephrology Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Nephrology Drugs Overall Market Size
2.1 Global Nephrology Drugs Market Size: 2021 VS 2028
2.2 Global Nephrology Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Nephrology Drugs Players in Global Market
3.2 Top Global Nephrology Drugs Companies Ranked by Revenue
3.3 Global Nephrology Drugs Revenue by Companies
3.4 Top 3 and Top 5 Nephrology Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Nephrology Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Nephrology Drugs Players in Global Market
3.6.1 List of Global Tier 1 Nephrology Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Nephrology Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Nephrology Drugs Market Size Markets, 2021 & 2028
4.1.2 ACE Inhibitors
4.1.3 Calcium Channel Blocker
4.1.4 Beta Blockers
4.1.5 Diuretics
4.1.6 Others
4.2 By Type - Global Nephrology Drugs Revenue & Forecasts
4.2.1 By Type - Global Nephrology Drugs Revenue, 2017-2022
4.2.2 By Type - Global Nephrology Drugs Revenue, 2023-2028
4.2.3 By Type - Global Nephrology Drugs Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Nephrology Drugs Market Size, 2021 & 2028
5.1.2 Hospital Pharmacy
5.1.3 Retail Pharmacy
5.1.4 Online Pharmacy
5.2 By Application - Global Nephrology Drugs Revenue & Forecasts
5.2.1 By Application - Global Nephrology Drugs Revenue, 2017-2022
5.2.2 By Application - Global Nephrology Drugs Revenue, 2023-2028
5.2.3 By Application - Global Nephrology Drugs Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Nephrology Drugs Market Size, 2021 & 2028
6.2 By Region - Global Nephrology Drugs Revenue & Forecasts
6.2.1 By Region - Global Nephrology Drugs Revenue, 2017-2022
6.2.2 By Region - Global Nephrology Drugs Revenue, 2023-2028
6.2.3 By Region - Global Nephrology Drugs Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Nephrology Drugs Revenue, 2017-2028
6.3.2 US Nephrology Drugs Market Size, 2017-2028
6.3.3 Canada Nephrology Drugs Market Size, 2017-2028
6.3.4 Mexico Nephrology Drugs Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Nephrology Drugs Revenue, 2017-2028
6.4.2 Germany Nephrology Drugs Market Size, 2017-2028
6.4.3 France Nephrology Drugs Market Size, 2017-2028
6.4.4 U.K. Nephrology Drugs Market Size, 2017-2028
6.4.5 Italy Nephrology Drugs Market Size, 2017-2028
6.4.6 Russia Nephrology Drugs Market Size, 2017-2028
6.4.7 Nordic Countries Nephrology Drugs Market Size, 2017-2028
6.4.8 Benelux Nephrology Drugs Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Nephrology Drugs Revenue, 2017-2028
6.5.2 China Nephrology Drugs Market Size, 2017-2028
6.5.3 Japan Nephrology Drugs Market Size, 2017-2028
6.5.4 South Korea Nephrology Drugs Market Size, 2017-2028
6.5.5 Southeast Asia Nephrology Drugs Market Size, 2017-2028
6.5.6 India Nephrology Drugs Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Nephrology Drugs Revenue, 2017-2028
6.6.2 Brazil Nephrology Drugs Market Size, 2017-2028
6.6.3 Argentina Nephrology Drugs Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Nephrology Drugs Revenue, 2017-2028
6.7.2 Turkey Nephrology Drugs Market Size, 2017-2028
6.7.3 Israel Nephrology Drugs Market Size, 2017-2028
6.7.4 Saudi Arabia Nephrology Drugs Market Size, 2017-2028
6.7.5 UAE Nephrology Drugs Market Size, 2017-2028
7 Players Profiles
7.1 AstraZeneca
7.1.1 AstraZeneca Corporate Summary
7.1.2 AstraZeneca Business Overview
7.1.3 AstraZeneca Nephrology Drugs Major Product Offerings
7.1.4 AstraZeneca Nephrology Drugs Revenue in Global Market (2017-2022)
7.1.5 AstraZeneca Key News
7.2 Pfizer
7.2.1 Pfizer Corporate Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Nephrology Drugs Major Product Offerings
7.2.4 Pfizer Nephrology Drugs Revenue in Global Market (2017-2022)
7.2.5 Pfizer Key News
7.3 Amgen
7.3.1 Amgen Corporate Summary
7.3.2 Amgen Business Overview
7.3.3 Amgen Nephrology Drugs Major Product Offerings
7.3.4 Amgen Nephrology Drugs Revenue in Global Market (2017-2022)
7.3.5 Amgen Key News
7.4 FibroGen
7.4.1 FibroGen Corporate Summary
7.4.2 FibroGen Business Overview
7.4.3 FibroGen Nephrology Drugs Major Product Offerings
7.4.4 FibroGen Nephrology Drugs Revenue in Global Market (2017-2022)
7.4.5 FibroGen Key News
7.5 GlaxoSmithkline
7.5.1 GlaxoSmithkline Corporate Summary
7.5.2 GlaxoSmithkline Business Overview
7.5.3 GlaxoSmithkline Nephrology Drugs Major Product Offerings
7.5.4 GlaxoSmithkline Nephrology Drugs Revenue in Global Market (2017-2022)
7.5.5 GlaxoSmithkline Key News
7.6 AbbVie
7.6.1 AbbVie Corporate Summary
7.6.2 AbbVie Business Overview
7.6.3 AbbVie Nephrology Drugs Major Product Offerings
7.6.4 AbbVie Nephrology Drugs Revenue in Global Market (2017-2022)
7.6.5 AbbVie Key News
7.7 Akebia Therapeutics
7.7.1 Akebia Therapeutics Corporate Summary
7.7.2 Akebia Therapeutics Business Overview
7.7.3 Akebia Therapeutics Nephrology Drugs Major Product Offerings
7.7.4 Akebia Therapeutics Nephrology Drugs Revenue in Global Market (2017-2022)
7.7.5 Akebia Therapeutics Key News
7.8 Teva Pharmaceutical Industries
7.8.1 Teva Pharmaceutical Industries Corporate Summary
7.8.2 Teva Pharmaceutical Industries Business Overview
7.8.3 Teva Pharmaceutical Industries Nephrology Drugs Major Product Offerings
7.8.4 Teva Pharmaceutical Industries Nephrology Drugs Revenue in Global Market (2017-2022)
7.8.5 Teva Pharmaceutical Industries Key News
7.9 Johnson & Johnson
7.9.1 Johnson & Johnson Corporate Summary
7.9.2 Johnson & Johnson Business Overview
7.9.3 Johnson & Johnson Nephrology Drugs Major Product Offerings
7.9.4 Johnson & Johnson Nephrology Drugs Revenue in Global Market (2017-2022)
7.9.5 Johnson & Johnson Key News
7.10 Roche
7.10.1 Roche Corporate Summary
7.10.2 Roche Business Overview
7.10.3 Roche Nephrology Drugs Major Product Offerings
7.10.4 Roche Nephrology Drugs Revenue in Global Market (2017-2022)
7.10.5 Roche Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Nephrology Drugs Market Opportunities & Trends in Global Market
Table 2. Nephrology Drugs Market Drivers in Global Market
Table 3. Nephrology Drugs Market Restraints in Global Market
Table 4. Key Players of Nephrology Drugs in Global Market
Table 5. Top Nephrology Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Nephrology Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Nephrology Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Nephrology Drugs Product Type
Table 9. List of Global Tier 1 Nephrology Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Nephrology Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Nephrology Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Nephrology Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Nephrology Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Nephrology Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Nephrology Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Nephrology Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Nephrology Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Nephrology Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Nephrology Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Nephrology Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Nephrology Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Nephrology Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Nephrology Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Nephrology Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Nephrology Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Nephrology Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Nephrology Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Nephrology Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Nephrology Drugs Revenue, (US$, Mn), 2023-2028
Table 30. AstraZeneca Corporate Summary
Table 31. AstraZeneca Nephrology Drugs Product Offerings
Table 32. AstraZeneca Nephrology Drugs Revenue (US$, Mn), (2017-2022)
Table 33. Pfizer Corporate Summary
Table 34. Pfizer Nephrology Drugs Product Offerings
Table 35. Pfizer Nephrology Drugs Revenue (US$, Mn), (2017-2022)
Table 36. Amgen Corporate Summary
Table 37. Amgen Nephrology Drugs Product Offerings
Table 38. Amgen Nephrology Drugs Revenue (US$, Mn), (2017-2022)
Table 39. FibroGen Corporate Summary
Table 40. FibroGen Nephrology Drugs Product Offerings
Table 41. FibroGen Nephrology Drugs Revenue (US$, Mn), (2017-2022)
Table 42. GlaxoSmithkline Corporate Summary
Table 43. GlaxoSmithkline Nephrology Drugs Product Offerings
Table 44. GlaxoSmithkline Nephrology Drugs Revenue (US$, Mn), (2017-2022)
Table 45. AbbVie Corporate Summary
Table 46. AbbVie Nephrology Drugs Product Offerings
Table 47. AbbVie Nephrology Drugs Revenue (US$, Mn), (2017-2022)
Table 48. Akebia Therapeutics Corporate Summary
Table 49. Akebia Therapeutics Nephrology Drugs Product Offerings
Table 50. Akebia Therapeutics Nephrology Drugs Revenue (US$, Mn), (2017-2022)
Table 51. Teva Pharmaceutical Industries Corporate Summary
Table 52. Teva Pharmaceutical Industries Nephrology Drugs Product Offerings
Table 53. Teva Pharmaceutical Industries Nephrology Drugs Revenue (US$, Mn), (2017-2022)
Table 54. Johnson & Johnson Corporate Summary
Table 55. Johnson & Johnson Nephrology Drugs Product Offerings
Table 56. Johnson & Johnson Nephrology Drugs Revenue (US$, Mn), (2017-2022)
Table 57. Roche Corporate Summary
Table 58. Roche Nephrology Drugs Product Offerings
Table 59. Roche Nephrology Drugs Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Nephrology Drugs Segment by Type in 2021
Figure 2. Nephrology Drugs Segment by Application in 2021
Figure 3. Global Nephrology Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Nephrology Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Nephrology Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Nephrology Drugs Revenue in 2021
Figure 8. By Type - Global Nephrology Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Nephrology Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Nephrology Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Nephrology Drugs Revenue Market Share, 2017-2028
Figure 12. US Nephrology Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Nephrology Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Nephrology Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Nephrology Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Nephrology Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Nephrology Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Nephrology Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Nephrology Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Nephrology Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Nephrology Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Nephrology Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Nephrology Drugs Revenue Market Share, 2017-2028
Figure 24. China Nephrology Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Nephrology Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Nephrology Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Nephrology Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Nephrology Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Nephrology Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Nephrology Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Nephrology Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Nephrology Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Nephrology Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Nephrology Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Nephrology Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Nephrology Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. AstraZeneca Nephrology Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Pfizer Nephrology Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Amgen Nephrology Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. FibroGen Nephrology Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. GlaxoSmithkline Nephrology Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. AbbVie Nephrology Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Akebia Therapeutics Nephrology Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Teva Pharmaceutical Industries Nephrology Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Johnson & Johnson Nephrology Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Roche Nephrology Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
67